Is if time to shift to better characterization of patients in trials assessing novel antidepressants? An example of two relapse prevention studies with agomelatine

Goodwin GM ; Boyer P ; Emsley RA ; Rouillon F ; de Bodinat C (2013)

Please help populate SUNScholar with the full text of SU research output. Also - should you need this item urgently, please send us the details and we will try to get hold of the full text as quick possible. E-mail to Thank you.

Journal Articles (subsidised)

Geneeskunde en Gesondheidswetenskappe


Please refer to this item in SUNScholar by using the following persistent URL:
This item appears in the following collections: